Ethiopian Lives
-
The new battleground for commercial card providers: Rewards and flexibility, Ascenda report revealsDetails
Fintech disruption and evolving rewards reshape business spending landscape NEW YORK,Dec. 10,2024-- Ascenda,the global leader in loyalty as a service,today released its 2024 State of Loyalty: Commerci
-
Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral ReportDetails
ROCKVILLE,Md. and SUZHOU,China,Dec. 10,2024--Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet medi
-
Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular CareDetails
– Collaboration combines Terumo\'sePRISM™ precision medicine software platform with Medis\' QFR® technology –
-
SK chemicals and Hyundai Collaborate on Sustainable Automotive DevelopmentDetails
"Recycling Technology Applied to Automobiles" Completed the Study Car Project with Recycling Technology in Collaboration with Hyundai
-
State Grid Xuzhou Power Supply Company: Helping to boost the "green content" of industrial developmentDetails
XUZHOU,China,Dec. 10,2024-- Recently,theJiangzhuang Energy Storage Power Station,the first power grid-side energy storage project in Xuzhou City,Jiangsu Province,has successfully achieved full-capacit
-
J.F. Lehman & Company Raises $2.2 Billion for Oversubscribed Fund VIDetails
NEW YORK,Dec. 11,2024-- J.F. Lehman & Company ("JFLCO"),a leading middle-market private equity firm focused exclusively on the aerospace,defense,maritime,government and environmental se
-
Joget White Label Offering Empowers Digital Solutions Companies to Launch Their Own Branded PlatformsDetails
Accelerate Custom Digital Solutions with Joget AI-Powered White Label Platform COLUMBIA,Md.,Dec. 10,2024-- Joget,the global innovator in next-generation enterprise application development,introduced
-
Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 MonthsDetails
ROCKVILLE,Md. and SUZHOU,China,Dec. 10,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet med
-
Live from ASH 2024 | Ascentage Pharma Releases Updated Data of Bcl-2 Inhibitor Lisaftoclax in MDS that Demonstrates Potential Clinical Benefits and Favorable SafetyDetails
ROCKVILLE,Md. and SUZHOU,China,Dec. 10,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet med
-
KPM Analytics Expands AI and Software Development Operations to Drive InnovationDetails
The large state-of-the-art facility in Orem,Utah,allows KPM Analytics to expand our Artificial Intelligence and software development utilized across KPM\'s brand portfolio.